286 related articles for article (PubMed ID: 29098752)
1. Hemobilia immediately after transcatheter arterial chemoembolization using drug-eluting beads for hepatocellular carcinoma with intrahepatic bile duct invasion.
Nishi M; Saeki I; Yamasaki T; Maeda M; Hisanaga T; Iwamoto T; Matsumoto T; Hidaka I; Ishikawa T; Takami T; Sakaida I
Hepatol Res; 2018 Mar; 48(4):329-332. PubMed ID: 29098752
[TBL] [Abstract][Full Text] [Related]
2. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma.
Kang YJ; Lee BC; Kim JK; Yim NY; Kim HO; Cho SB; Jeong YY
Cardiovasc Intervent Radiol; 2020 Jan; 43(1):55-64. PubMed ID: 31646378
[TBL] [Abstract][Full Text] [Related]
3. Effect of drug-eluting bead transarterial chemoembolization loaded with cisplatin on normal dogs.
Nakasumi K; Yamamoto N; Takami T; Itoh H; Itamoto K; Horikirizono H; Iseri T; Nakaichi M; Nemoto Y; Sunahara H; Tani K
J Vet Med Sci; 2022 Jan; 84(1):114-120. PubMed ID: 34866073
[TBL] [Abstract][Full Text] [Related]
4. Delayed intratumoral hemorrhage after drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma.
Shiozawa K; Watanabe M; Ikehara T; Ogino Y; Umakoshi T; Matsukiyo Y; Kogame M; Matsui T; Kikuchi Y; Igarashi Y; Sumino Y
Case Rep Oncol; 2014 Sep; 7(3):739-45. PubMed ID: 25520649
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (<100 μm) Beads.
Chang WC; Hsu HH; Chiu SH; Huang WY; Lo CH; Lin HH; Huang PC; Shih YL; Wan YL
J Hepatocell Carcinoma; 2021; 8():937-949. PubMed ID: 34422707
[TBL] [Abstract][Full Text] [Related]
6. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
[TBL] [Abstract][Full Text] [Related]
7. Diffuse biliary peritonitis secondary to rupture of metastatic liver adenocarcinomas after drug-eluting bead transcatheter arterial chemoembolization: a case report.
Zhu LB; Li TF; Li JQ; Li PF; Zhang PB; Wu HB; Xv R
J Int Med Res; 2019 Jun; 47(6):2679-2686. PubMed ID: 30971156
[TBL] [Abstract][Full Text] [Related]
8. Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma.
Huang J; Huang W; Zhan M; Guo Y; Liang L; Cai M; Lin L; He M; Lian H; Lu L; Zhu K
J Hepatocell Carcinoma; 2021; 8():1445-1458. PubMed ID: 34858889
[TBL] [Abstract][Full Text] [Related]
9. Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular Carcinoma.
Liu KC; Lv WF; Lu D; Hou CL; Xie J; Lu YH; Cao QS; Tan YL; Zhang YZ; Liu J
Cancer Manag Res; 2021; 13():7973-7980. PubMed ID: 34703317
[TBL] [Abstract][Full Text] [Related]
10. Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization.
Kobayashi S; Tajiri K; Murayama A; Entani T; Futsukaichi Y; Nagata K; Takahashi K; Yasuda I
J Hepatocell Carcinoma; 2020; 7():181-189. PubMed ID: 33117752
[TBL] [Abstract][Full Text] [Related]
11. Increased Arterio-Portal Shunt Formation after Drug-Eluting Beads TACE for Hepatocellular Carcinoma.
Shimose S; Iwamoto H; Tanaka M; Niizeki T; Shirono T; Nakano M; Okamura S; Noda Y; Kamachi N; Sakai M; Suzuki H; Nomiyama M; Kuromatsu R; Koga H; Torimura T
Oncology; 2020; 98(8):558-565. PubMed ID: 32422633
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter hepatic arterial embolization followed by microwave ablation for hemobilia from hepatocellular carcinoma.
Takao Y; Yoshida H; Mamada Y; Taniai N; Bando K; Tajiri T
J Nippon Med Sch; 2008 Oct; 75(5):284-8. PubMed ID: 19023168
[TBL] [Abstract][Full Text] [Related]
13. Risk factors of liver abscess and biloma formation after drug-eluting bead transarterial chemoembolization for unresectable intrahepatic cholangiocarcinoma.
Bian L; Yang J; Song Z
Arab J Gastroenterol; 2024 May; 25(2):176-181. PubMed ID: 38388217
[TBL] [Abstract][Full Text] [Related]
14. Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Kloeckner R; Weinmann A; Prinz F; Pinto dos Santos D; Ruckes C; Dueber C; Pitton MB
BMC Cancer; 2015 Jun; 15():465. PubMed ID: 26059447
[TBL] [Abstract][Full Text] [Related]
15. The clinical safety and efficacy of conventional transcatheter arterial chemoembolization and drug-eluting beads-transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A meta-analysis.
Han T; Yang X; Zhang Y; Li G; Liu L; Chen T; Zheng Z
Biosci Trends; 2019 Nov; 13(5):374-381. PubMed ID: 31611486
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Huang K; Zhou Q; Wang R; Cheng D; Ma Y
J Gastroenterol Hepatol; 2014 May; 29(5):920-5. PubMed ID: 24224722
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tumor response following conventional versus drug-eluting bead transarterial chemoembolization in early- and very early-stage hepatocellular carcinoma.
Razi M; Safiullah S; Gu J; He X; Razi M; Kong J
J Interv Med; 2022 Feb; 5(1):10-14. PubMed ID: 35586278
[TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
[TBL] [Abstract][Full Text] [Related]
19. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.
Kokabi N; Camacho JC; Xing M; Edalat F; Mittal PK; Kim HS
J Magn Reson Imaging; 2015 Oct; 42(4):981-9. PubMed ID: 25683022
[TBL] [Abstract][Full Text] [Related]
20. Imaging response predictors following drug eluting beads chemoembolization in the neoadjuvant liver transplant treatment of hepatocellular carcinoma.
Galastri FL; Nasser F; Affonso BB; Valle LGM; Odísio BC; Motta-Leal Filho JM; Salvalaggio PR; Garcia RG; de Almeida MD; Baroni RH; Wolosker N
World J Hepatol; 2020 Jan; 12(1):21-33. PubMed ID: 31984118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
